| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome
|
MahmoudianDehkordi, Siamak
|
|
2019
|
15 |
1 |
p. 76-92
|
artikel
|
| 2 |
Alzheimer's Association Update
|
|
|
2019
|
15 |
1 |
p. 184
|
artikel
|
| 3 |
“Alzheimer's disease” is neither “Alzheimer's clinical syndrome” nor “dementia”
|
Jagust, William
|
|
2019
|
15 |
1 |
p. 153-157
|
artikel
|
| 4 |
Analysis of tauopathy research funding between 2006 and 2016 reveals critical gaps in research priorities
|
Altimus, Cara M.
|
|
2019
|
15 |
1 |
p. 42-54
|
artikel
|
| 5 |
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis
|
Latimer, Caitlin S.
|
|
2019
|
15 |
1 |
p. 93-105
|
artikel
|
| 6 |
Associations between recent and established ophthalmic conditions and risk of Alzheimer's disease
|
Lee, Cecilia S.
|
|
2019
|
15 |
1 |
p. 34-41
|
artikel
|
| 7 |
A systems-based model of Alzheimer's disease
|
Tang, Yi
|
|
2019
|
15 |
1 |
p. 168-171
|
artikel
|
| 8 |
Contents
|
|
|
2019
|
15 |
1 |
p. A1-A3
|
artikel
|
| 9 |
Editorial Board
|
|
|
2019
|
15 |
1 |
p. A4-A5
|
artikel
|
| 10 |
Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
|
Sandelius, Åsa
|
|
2019
|
15 |
1 |
p. 55-64
|
artikel
|
| 11 |
Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms
|
Lin, Yen-Feng
|
|
2019
|
15 |
1 |
p. 65-75
|
artikel
|
| 12 |
Medical and Scientific Advisory Council
|
|
|
2019
|
15 |
1 |
p. A6
|
artikel
|
| 13 |
Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease
|
Bell, W. Robert
|
|
2019
|
15 |
1 |
p. 8-16
|
artikel
|
| 14 |
Prediabetes and diabetes accelerate cognitive decline and predict microvascular lesions: A population-based cohort study
|
Marseglia, Anna
|
|
2019
|
15 |
1 |
p. 25-33
|
artikel
|
| 15 |
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study
|
Rajan, Kumar B.
|
|
2019
|
15 |
1 |
p. 1-7
|
artikel
|
| 16 |
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years
|
Matthews, Kevin A.
|
|
2019
|
15 |
1 |
p. 17-24
|
artikel
|
| 17 |
Subscriber Information
|
|
|
2019
|
15 |
1 |
p. A7
|
artikel
|
| 18 |
The National Institute on Aging—Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials
|
Cummings, Jeffrey
|
|
2019
|
15 |
1 |
p. 172-178
|
artikel
|
| 19 |
The National Institute on Aging and Alzheimer's Association research framework: A commentary from the Cochrane Dementia and Cognitive Improvement Group
|
McCleery, Jenny
|
|
2019
|
15 |
1 |
p. 179-181
|
artikel
|
| 20 |
The 2018 NIA-AA research framework: Recommendation and comments
|
Louie, Ron
|
|
2019
|
15 |
1 |
p. 182-183
|
artikel
|
| 21 |
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
|
Veitch, Dallas P.
|
|
2019
|
15 |
1 |
p. 106-152
|
artikel
|
| 22 |
Vascular dysfunction—The disregarded partner of Alzheimer's disease
|
Sweeney, Melanie D.
|
|
2019
|
15 |
1 |
p. 158-167
|
artikel
|
Tijdschrift beschrijving